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Available online 12 May 2016Lavender oil (LO) is a commonly used essential oil in aromatherapy as non-traditional medicine. With an aim to
demonstrate LO effects on the body, we have recently established an animal model investigating the inﬂuence of
orally administered LO in rat tissues, genome-wide. In this brief, we investigate the effect of LO ingestion in the
blood of rat. Rats were administered LO at usual therapeutic dose (5 mg/kg) in humans, and following collection
of the venous blood from the heart and extraction of total RNA, the differentially expressed genes were screened
using a 4 × 44-K whole-genome rat chip (Agilent microarray platform; Agilent Technologies, Palo Alto, CA, USA)
in conjunction with a two-color dye-swap approach. A total of 834 differentially expressed genes in the blood
were identiﬁed: 362 up-regulated and 472 down-regulated. These geneswere functionally categorized using bioin-
formatics tools. The gene expression inventory of rat blood transcriptomeunder LO, aﬁrst report, has beendeposited
into theGeneExpressionOmnibus (GEO): GSE67499. Thedatawill be a valuable resource in examining the effects of
natural products, and which could also serve as a human model for further functional analysis and investigation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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2. Experimental design, materials and methods
2.1. Lavender oil (LO) and experimental design for whole blood tran-
scriptome in rat
Our group has been studying the effects of lavender oil (hereafter,
LO) on rat model genome-wide [1] using the high-throughput DNA://creativecommons.org/licenses/by/4.0/).
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scribes the effects of oral ingestion of LO on the expression of genes in
the small intestine, spleen and liver [1]. DNAmicroarray-based proﬁling
using the Agilent platform has been efﬁciently utilized by our collabora-
tive group to provide a conﬁdent inventory of the time-dependent
mRNA level changes in global gene expression in diverse tissues in ani-
mal models [3–7]. Among these tissues, a complete study on the whole
blood transcriptome analysis was lacking. Experimenting on the blood
transcriptome in both animal (rat and mouse) and human subjects for
stress and neurodevelopmental disorders (Rakwal and co-workers, un-
published data), we have optimized a protocol for extracting good qual-
ity total RNA from whole blood, deep frozen immediately in liquid
nitrogen, for downstream DNA microarray analysis, and which is one
subject of this present research. Moreover, the genomic data from
blood (cells) is becoming an important tool in our search for potential
biomarkers for health/disease [8,9]. Two pitfalls remain, ﬁrst, a protocol
for total RNA extraction from whole deep-frozen blood, and second,
demonstration of the transcript proﬁles in a DNA microarray-based
study in a (animal) rat model.
In the present study, utilizing the rat model for an aromatherapy
study of essential oil of lavender (LO) as an example, we have investi-
gated the whole blood for genome-wide expression proﬁling of genes
affected by oral intake of LO. Brieﬂy, to explain about LO, the oil distilled
from the Labiatae family member— Lavandula angustifolia is the source
for the commonly used oil in aromatherapy [10,11]. The essential oil of
lavender has been traditionally used in some European countries [1,12]
rather than in Japan or other Asian countries, where aromatherapy is
widely usedmostly through inhalation of volatile components or appli-
cation of diluted oil to the skin [1,13]. Although, and asmentioned in the
previous LOpaper, in France, BelgiumandGermany, LO is used as a form
of herbal or natural medicine [1]. To note, a German pharmaceutical
company also produces an encapsulated form of LO, “Silexan” and
which is sold commercially under the trade name LASEA (W. Spitzner
Arzmeimittelfabrik GmbH, Ettlingen, Germany). Although the safetyFig. 1.DNAmicroarray and bioinformatics analyses in the blood of rats after oral ingestion of the
13 days, and on the 14th day, the blood from the heart was sampled. The blood whole-genom
publically available under the GEO series number GSE 67499. Differentially expressed genes
described in the text.aspects of ingesting essential oils might still be of concern, it is to note
that a clinical study has shown positive beneﬁcial effects of Silexan
[14]. This was also reason for us to carry out the LO study using rats
who ingested the essential oil [1].
To continue our research forward into potential beneﬁcial effects of
LO, and to study thewhole blood transcriptome inﬂuenced by LO inges-
tion, we used the experimental design and strategy as shown in Fig. 1.
Essentially, following the LO rat model set up [1] and using the
established DNA microarray approach in our laboratories, we have
successfully extracted total RNA from freshly taken whole blood
(deep-frozen) for use in downstream gene expression proﬁling,
genome-wide, a ﬁrst such report.
Rat model, oral administration of LO, extraction of whole blood and total
RNA isolation
Brieﬂy, rats (Fischer, F334) were purchased from Japan SCL (Ha-
mamatsu, Japan) and a total of 12 male rats (7 weeks old, ~142.8 to
167.5-g body weight) were housed at the Animal Institution in
Showa University. Individual cages were used to maintain the rats
in isolated animal rooms with controlled temperature and relative
humidity with a 12 h light/12 h dark schedule (lights turned on at
08:00 AM). Rats had access to laboratory chow and tap water ad
libitum. At least one-week acclimation period was allowed for the
rats in the animal room prior to the conduct of the experiment. All
of the animal care and experimental procedures were approved by
the Institutional Animal Care and Use Committee of Showa Universi-
ty (approval number M6031).
The essential oil of lavender (LO, L. angustifolia, Bioﬂoral, France)was
administered to rats (n = 6 each group: control and LO treatment) di-
rectly into the stomach at a dose of 0 (10% ethanol; diluent: control
group) or 5 mg/kg (in 10% ethanol: LO-administered group) once a
day in the afternoon (11:25–13:50) for 13 days. Fourteen days after
treatment, the rats were dissected under ether anesthesia and thelavender oil (LO). Seven-week-old rats were orally administered the LO, once each day for
e DNA microarray analysis was performed using the Agilent platform. Microarray data are
were identiﬁed in the LO-treated blood sample followed by bioinformatics analyses as
141M. Hori et al. / Genomics Data 8 (2016) 139–145whole blood was taken directly from the heart. The whole blood was
put into 2 mL sterile Eppendorf tubes, which were then quickly im-
mersed in liquid nitrogen (N2) before being stored in a−80 °C deep
freezer for downstream analysis. To note, the whole blood indicates
no centrifugation to separate into plasma and serum prior to storage.
The microfuge tube containing the deep-frozen whole blood was
placed on the bench at room temperature, and around 0.6 mL of theFig. 2.Ratwhole blood total RNA extraction protocol, andDNAmicroarray analysis after oral inge
Blood was sampled as described in Fig. 1, and an optimized guanidium thiocynate method wa
approach was employed for conﬁdent gene expression proﬁling in the blood of LO treated ratblood was removed to a new sterile microfuge tube, and immediately
processed for total RNA extraction as schematically presented in detail
in Fig. 2A. Brieﬂy, the guanidium thiocynatemethodwas used in combi-
nation with the QIAamp spin columns (QIAGEN RNeasy Mini Kit,
QIAGEN, Maryland, MD, USA), which have been used downstream
of the ﬁrst individual RNA extraction step depending on each tissue
[1,3–7].stion of the lavender oil (LO) reveals 362up-regulated and 472 down-regulated genes. (A)
s used for total RNA extraction from deep frozen whole blood. (B) A two-color dye swap
using the Agilent 4 × 44 K DNA microarray chip.
Fig. 3. Pathway- and disease states-focused gene classiﬁcation of genes in thewhole blood
of LO-treated rats. The genes (up-regulated— blue; down-regulated— red)were classiﬁed
based on the available categories of more than 100 biological pathways or speciﬁc disease
states in the SABiosciences PCR array list (QIAGEN; www.sabiosciences.com) for Rattus
norvegicus. The gene functions are indicated on the left-hand side, and the numbers on
the top of the chart represent the number of genes in each functional category.
142 M. Hori et al. / Genomics Data 8 (2016) 139–1452.3. Whole blood whole-genome DNA microarray analysis
The extractedwhole blood total RNA for each control and LO-admin-
istered sample was pooled [1,15,16] in each group prior to DNAFig. 4. The top three networks (1, 2, and 3) for the rat whole blood under LO treatment by IPA a
the evidence in the IPA.microarray analysis, which was performed using a Rat whole genome
4 × 44-K DNA chip (G4131F; Agilent Technologies, Palo Alto, CA, USA)
(Fig. 2B). Brieﬂy, the total RNA (200 ng) was labeled with either Cy3
or Cy5 dye using an Agilent Low-RNA-Input Fluorescent Linear Ampliﬁ-
cation Kit (Agilent Technologies). The ﬂuorescently labeled targets of
the control as well as the LO-treated samples were hybridized to the
same microarray slide with 60-mer probes. A ﬂip-labeling (dye-swap
or reverse labeling with Cy3 and Cy5 dyes) procedure was followed to
nullify the dye bias that was associated with the unequal incorporation
of the two Cy dyes into cDNA. The use of a dye-swap approach provides
more-stringent selection conditions for changed gene expression pro-
ﬁling than the use of a simple single/two-color approach [6]. For the
selection of differentially expressed genes by the dye-swap approach,
we considered genes that were up-regulated in chip 1 (Cy3/Cy5 label
for control and LO-administered samples, respectively) but down-
regulated in chip 2 (Cy3/Cy5 label for LO-administered and control
samples, respectively).
Hybridization and wash processes were performed according
to the manufacturer's instructions, and the hybridized microarrays
were scanned using an Agilent Microarray scanner G2505C. To
detect signiﬁcantly differentially expressed genes between the con-
trol and treated samples, each slide image was processed using
Agilent Feature Extraction software (version 11.0.1.1). This program
measures the Cy3 and Cy5 signal intensities of whole probes.
Dye bias tends to be signal-intensity-dependent; therefore, the soft-
ware selected probes using a set-by-rank consistency ﬁlter for dye
normalization. Said normalization was performed by LOWESS
(locally weighted linear regression), which calculates the log ratio
of dye-normalized Cy3 and Cy5 signals and the ﬁnal error of the
log ratio. Statistical signiﬁcance of the log ratio values obtained
for individual microarray probes was calculated using the “most
conservative error model” default function of the Feature Extraction
software, by which both a propagated and a universal error model
are evaluated, and the higher (more conservative estimate of
error) p-value of two error models was reported [6; Agilent Tech-
nologies]. For the analyses, the threshold of signiﬁcant differentially
expressed genes was b0.01 (for the conﬁdence that the feature was
not differentially expressed). Additionally, the erroneous data gen-
erated due to artifacts were eliminated before data analysis by the
software.2.4. Functional categorization of differentially expressed genes in the whole
blood after LO ingestion and ingenuity pathway analysis of the whole blood
transcriptome
We performed the pathway and disease state-focused gene classiﬁ-
cation of the differentially expressed whole blood genes based on the
available categories of more than 100 biological pathways or speciﬁc
disease states in the SABiosciences PCR array list (QIAGEN; www.
sabiosciences.com) for Rattus norvegicus.
Biological function and network analyses were performed using In-
genuity Pathway Analysis (IPA; Ingenuity® Systems, www.ingenuity.
com) tool. The dataset from the microarray (LO treatment in the
whole blood), which includes the differentially expressed (≧/≦1.5/
0.75-fold compared with control) genes and their corresponding
fold change values, was uploaded as an Excel spread sheet into the
IPA tool. To create gene networks, the genes were overlaid onto
a global molecular network that was developed from information that
was contained in the ingenuity knowledge base. The functional
analysis identiﬁed the biological functions that were most signiﬁcant
to the dataset (p-value b 0.05) according to a right-tailed Fisher's
exact test.nalysis. The genes (up-regulated— red; down-regulated— green) are networked based on
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3.1. Differentially expressed genes in the whole blood of rat after LO
treatment
Utilizing an optimized total RNA extraction protocol for the whole
blood, from rat orally administered LO, and as described in Fig. 2A, the
two-color dye-swap DNAmicroarray analysis revealed 834 differential-
ly expressed genes in thewhole blood of rat given LO.Whole blood is an
important target for analysis, as the sample can be immediately frozen
or extracted without separation into plasma-serum, and the gene ex-
pressions unraveled in the blood can be compared with other tissues/
organs, such as small intestine, liver, spleen, and brain those of which
are also our interest. As also mentioned above, extraction of good qual-
ity total RNA from the blood is not easy, especially as a critical require-
ment in high-throughput omics-based DNA microarray approaches,
a protocol for total RNA extraction from whole deep-frozen blood was
optimized and used in this present study (Fig. 2A). Among these,
362 genes were up-regulated and 472 genes were down-regulated
(Fig. 2B). These genes are listed in Supplementary Table 1. The outputs
(raw data) of the microarray analysis that were used in this study are
open and freely available under the number series GSE 67499 (whole
genome) at the NCBI Gene Expression Omnibus (GEO) public functional
genomics data repository.
3.2. Bioinformatics analysis provides a hint on the function and networks of
genes in LO treated rat whole blood
The SABiosciences PCR array list (QIAGEN)was utilized to functionally
categorize the differentially expressed whole blood genes, the results of
which are presented graphically in Fig. 3. The annotated gene function
and the genes description contained within each functional category are
shown for the up-regulated (Supplementary Table 2) and down-regulat-
ed (Supplementary Table 3) genes. The number of down regulated genes
was more highly annotated than the up-regulated genes, where some
functions were more represented than others. For example, in the up-Fig. 5. The top molecules for the rat whole blood under LO treatment by IPA analysis. The genregulated gene list, synaptic plasticity, osteogenesis and hypertension
were the categories with the most annotated genes. In the case of
down-regulated gene list, molecular toxicology pathway ﬁnder, endothe-
lial cell biology and nuclear receptors and coregulators were the catego-
ries with the most annotated genes. For a wider bioinformatics analysis,
the biological function and network analysis was performed using the
IPA tool. Numerous networks and pathways that were generated by this
analysis revealed that LO can affect the blood in complexways. For exam-
ple, the genes inﬂuenced by LO in the top three networks (1, 2, and 3) are
presented in Fig. 4. The blood IPA analysis also provided a list of top mol-
ecules that are gene candidates for the potential mechanism/s underlying
the LO effects in the rat model (Fig. 5).
The top-regulated gene was Ppapdc3, also known as phospholipid
phosphatase 7 (plpp7). Although, there is no research indicating its ex-
pression under essential oils, a literature review showed that it is a nu-
clear envelope protein which is involved in the signaling process,
functioning as a negative regulator of myoblast differentiation [17].
The Ndufaf1 (NADH dehydrogenase (ubiquinone) 1α-subcomplex, as-
sembly factor 1) genewas themost down-regulated factor. Ndufaf1 en-
codes a complex I assembly factor protein. Although it is an important
protein for mitochondrial function, we do not know the reason for its
decrease in the blood after LO treatment.
Lavender oil (LO) is used as a traditional medicine in aromatherapy
for a wide variety of stresses. However, the molecular basis for its ben-
eﬁcial effects remains unclear. This study provides researchers with a
new resource in terms of genes that are up- or down-regulated in the
whole blood. As identiﬁcation of these genes are a ﬁrst such report
from the blood of rat, our results also conﬁrm the importance of a
DNA microarray analysis approach in shedding light behind the use of
LO and its effects on the body. Numerous gene candidates identiﬁed
here will form the basis for future research and to compare with the
genes in other tissues/organs of the rat, for a proper understanding of
their function under LO.
Supplementarymaterial for this article has been submitted online as
individual ﬁles. Supplementary data associated with this article can be
found in the online version, at doi 10.1016/j.gdata.2016.05.005.es (up-regulated— red; down-regulated — green) are based on the evidence in the IPA.
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